Remove tag hybrid-healthcare
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. IBM said it “remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.”

Radiology 109
article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. Types of Big Data in Healthcare Structured Data: Structured data is quantitative data in the form of numbers and values that can be processed, stored, and retrieved in a fixed format.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

This ultimately impacts patient perception of healthcare services in general. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. In this future, everyone wins – patients, pharma companies, physicians, and the overall healthcare ecosystem.

article thumbnail

Grand Rounds February 17, 2023: The Heartline Trial: A New Paradigm in Conducting Virtual Clinical Trials (C. Michael Gibson, MS, MD)

Rethinking Clinical Trials

The question is can we pivot from very expensive trials to test cardiovascular drugs to at least a hybrid model that takes the best of what we have learned so far from the Heartline Trial? Digital health is upon us, and we want to make sure that technology works for healthcare and that healthcare should not work for technology.

article thumbnail

Life Sciences 2022 Year in Review

XTalks

As the world continues to experience the effects and aftermath of the COVID-19 pandemic, lessons learned from the biggest global health crisis in recent times spurred changes and adaptations in the life sciences and healthcare. Here are some of the top life science trends and topics from 2022. Gene Therapy Approvals.

article thumbnail

A roadmap for adopting New Science 

pharmaphorum

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. People simply can’t afford them. And governments struggle to manage costs.